CLASS II ONGOING Device recall · Reported 22 Mar 2023 · FDA Enforcement Report

ExacTrac Dynamic recalled by Brainlab AG

Brainlab is recalling ExacTrac Dynamic, distributed nationwide in the US. The recall was initiated on 14 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVersions 1.1.0 and 1.1.1, GTIN: 04056481143978.
Quantity recalled56 systems in the U.S.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1259-2023
FDA event ID
91664
Recalling firm
Brainlab, Munich, N/A
Classification
Class II
Status
Ongoing
Recall initiated
14 Feb 2023
FDA classified
16 Mar 2023
Reported
22 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

14 Feb 2023Recall initiated by company
16 Mar 2023Classified by FDA+30 days
22 Mar 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Deep Inspiration Breath Hold (DIBH) functionality may not work as specified when based on a standard-workflow Treatment Template

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Brainlab ExacTrac Dynamic software, Medical Charged-Particle Radiation Therapy System, model 20910-01E and 20910-01F.

Where it was distributed

US Nationwide distribution in the states of AZ, AR, CA, CO, FL, GA. IL, IN, KY, LA, MS, MO, NJ, NY, NC, ND, OK, OR, PA, TN, TX, VA, and WA. There was no government/military distribution.

Nationwide ArkansasArizonaCaliforniaColoradoFloridaGeorgiaIllinoisIndianaKentuckyLouisianaMissouriMississippiNorth CarolinaNorth DakotaNew JerseyNew YorkOklahomaOregonPennsylvaniaTennessee

Questions about this recall

Why was it recalled?

Deep Inspiration Breath Hold (DIBH) functionality may not work as specified when based on a standard-workflow Treatment Template

Which lots are affected?

Versions 1.1.0 and 1.1.1, GTIN: 04056481143978.

Where was it sold?

US Nationwide distribution in the states of AZ, AR, CA, CO, FL, GA. IL, IN, KY, LA, MS, MO, NJ, NY, NC, ND, OK, OR, PA, TN, TX, VA, and WA. There was no government/military distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Brainlab

All 39

Other Medical Software recalls

All 932